SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " clinical " 974 found 🔀 AI-powered Shuffle
US Stand Up for Science movement expands to Europe
A grassroots movement by scientists in the US pushing back against threats to academic freedom is setting up a Swiss outpost to take the movement global. Stand Up for Science started in February 2025 to protest against politically-motivated grant cancellations by the Trump administration. Since then, it has organised numerous rallies by scientists and turned into a broader campaigning organisation, supporting “pro-science” political candidates and attempting to impeach Robert F. Kennedy Jr, the health and human services secretary the group accuses of advancing “quack” science. Now, Stand Up for Science is establishing a Swiss office to take some of its campaigning beyond the US, and its leader is urging European academics to organise similar pro-science groups in case they face similar threats in Europe. There will likely be “spillover” to Europe from what the Trump administration is attempting in the US, said Colette Delawalla, chief executive of Stand Up for Science, who last month returned from a tour of Europe. “Are we going to see a Trump-style scientific [. . .] take over in the same way?” she asked.Delawalla, who is doing a PhD in clinical psychology, said she was driven to help found the organisation after the Trump administration started cancelling health research grants in politically taboo topics, such as transgender people, diversity and HIV, in early 2025. Since then, the administration has introduced several other measures that infringe academic and institutional autonomy.It threatened to cut Harvard University’s federal funding unless the university accepted a “critical mass” of new faculty and students to create “viewpoint diversity.” And this year, it proposed explosive new rules that would allow political appointees at research funders to screen grants to make sure they “advance the president's policy priorities.”US scientists have been at times stunned by the volume of announcements, and the country’s researchers were relatively unprepared. “We sit in front of the fire hose every day,” said Delawalla. For this reason, European scientists need to prepare now for similar assaults. “If you've got a little bit of extra time to start thinking through, and making those preparations and building community and solidarity,” then European researchers will “start five steps ahead of where we were.” She plans to return to Paris in September to share experiences with concerned French academics. Is Le Pen the same?During her European tour, Delawalla said that French academics were beginning to worry about a National Rally (RN) victory in presidential elections next year. She said there were “chilling similarities” between Trump and Marine Le Pen, the RN’s likely candidate. However, so far, the RN hasn’t proposed anything nearly as radical as the Trump administration has carried out. Its current manifesto is all but silent on university and research policy. Le Pen’s 2022 manifesto bemoaned a lack of French R&D spending, including in fundamental research, and promised to modernise labs and strip away grant bureaucracy. The party’s 2024 European election manifesto explicitly supported the Erasmus+ student exchange programme, scientific exchange and joint European technology projects. However, a Le Pen victory next year could see France drastically cut its contribution to the EU, which would hit the budget for science and innovation. Meanwhile, more restrictive immigration policies could hit university recruitment of faculty and students. Climate science denial?As heatwaves and wildfires have ravaged France, the RN has sought to distance itself from previous comments casting doubt on climate science.In the UK, the radical-right party Reform UK, now second in the polls, denied climate research in a draft of its 2024 election manifesto, but its leader, Nigel Farage, then appeared to quietly U-turn and said he was “not arguing the science.” By contrast, Trump has repeatedly and explicitly denied climate change science, in 2025 calling it “the greatest con job.” Like the RN, Reform UK has been light on research and university policy. However, it did say in its 2024 manifesto that universities should suffer “heavy financial penalties” for allowing “political bias or cancel culture” on campus, building on laws brought in by a previous Conservative government. Ahead of September state elections in Saxony-Anhalt in Germany, the poll-leading Alternative for Germany has proposed abolishing gender studies and postcolonial studies, and promised money for “critical” climate research and studies of Islam. Starts with rhetoricEven if European radical right parties aren’t currently planning the draconian policy measures of the Trump administration, Delawalla said that academics should not be complacent, and fight even small funding restrictions or anti-science talk from the start. “It starts off with sowing distrust about institutions,” she said. “It starts off with these small things, and then all of a sudden it's there.” There are other, more established science and university advocacy groups in the US aside from Stand Up for Science. But the group stands out because of Delawalla’s refusal to attempt to appear politically bipartisan or conciliatory. “I firmly believe that the US is experiencing fascism,” she said. “We’re not trying to win over the super Maga people,” she said, “and we never have been.” The lesson of the US is that even if universities or other institutions capitulate to government demands, this doesn’t save them from cuts and restrictions. “It doesn’t matter what people do,” she said. Global “pseudoscience”Another aim of Stand Up for Science’s push into Europe is to better coordinate a campaign to protect people in poorer countries from what the group describes as “pseudoscientific exploitation,” trials outside the US used to build a case against things like vaccines. Earlier this year, the group sent an investigator to Guinea-Bissau to investigate a controversial, Danish-run Hepatitis B vaccine project funded by the US Centers for Disease Control and Prevention.The study would have withheld a proven vaccine from newborns, Stand Up for Science argued in a briefing it presented to Congress, risking their health. Significantly, the research group based in Guinea-Bissau, known as Bandim, focuses on the “non-specific effects” of vaccines: impacts on health beyond preventing the target disease. Related articlesEuropean researchers sound the alarm that Trump rule changes will hit cooperationData corner: which fields of health science is the US curbing? The US ‘golden age’ science strategy: what Europeans need to know The suspicion is that the study was funded as part of an attempt to shop around for results that could help build a case against vaccines in the US, said Delawalla. “This is just code for vaccines cause autism,” she said.Bandim has put out a rebuttal of Stand Up for Science’s criticisms, arguing its work has uncovered a number of vaccine side effects, both positive and negative, which need to be taken into account in public health. However, Congressional Democrats took up the Stand Up for Science cause, and in February, Guinea-Bissau said it had permanently halted the study. WatchdogBut for Delawalla, this is not the end of the fight. Kennedy has made a number of health claims that scientists think lack evidence, such as the idea that seed oils cause inflammation, for example. Delawalla worries that more studies could be launched in poorer countries to fish around for evidence to support this agenda. Stand Up for Science is talking to African science organisations to create a kind of “watchdog” to scrutinise any further trials. “Outsourcing the investigation to some of the most vulnerable children in the world who are desperate [. . .] is fundamentally wrong,” she said.
Experts share MRI efficiency strategies that could raise revenue by upward of 60%
Workflow redesigns have the potential to improve MRI throughput by 20%, while AI-based protocol optimization could boost efficiencies by another 35%, experts write in Clinical Imaging.
Clopidogrel monotherapy bests aspirin when patients with diabetes undergo PCI
After an initial period of DAPT, what's the best next step? A new analysis reviewed data from the SMART-CHOICE 3 clinical trial.
Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI
Federal health officials invited tech companies and lobbyists to closed-door meetings as they seek to boost adoption of clinical AI.
Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’
Sanofi halted a phase 2 trial testing a monoclonal antibody, SAR445399, in non-cystic fibrosis bronchiectasis, Fierce Biotech has learned. The trial, which began only back in April, was a randomized, double-blind, placebo-controlled study to measure the reduction in mucus plug score following treatment with SAR445399 compared with placebo in adults aged 18 to 80 years with NCFB, a chronic lung disease. The trial was officially reported as halted on July 29, the day before Sanofi’s second-quarter earnings call. The decision to pause the trial was made “as part of a company-wide portfolio review for strategic business reasons,” and not due to safety concerns, a Sanofi spokesperson told Fierce. The move to pause the NCFB trial comes during a trying time for Sanofi following a year filled with a series of trial fails. In February, the French pharma ousted CEO Paul Hudson and appointed Merck KGaA leader Belén Garijo, M.D., Ph.D., to steer the ship. Since then, Garijo has been doing a deep dive on correcting the company’s strewn R&D and clinical strategies. On July 24, Sanofi scrapped amlitelimab for atopic dermatitis, despite its lore as being a potential $5 billion blockbuster. During its second-quarter report, the company abandoned two more assets, balinatunfib and itepekimab, following failed trial results in psoriasis and chronic obstructive pulmonary disease, respectively. SAR445399, only first revealed by Sanofi in 2023, is an anti-interleukin-1 receptor 3 monoclonal antibody developed to block the interleukin 1, 33, and 36 cytokine pathways. These pathways can be important in chronic immune-related dermatologic diseases, such as atopic dermatitis and hidradenitis suppurativa, as well as respiratory conditions, such as NCFB. Related Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues NCFB affects roughly half a million people in the U.S., with a global incidence of greater than one million cases. In August 2025, Insmed received FDA approval for Brinsupri, a DPP1 inhibitor targeting neutrophil activation, for treatment of NCFB in adults and kids ages 12 and older. The British biotech Infex Therapeutics showed promising NCFB phase 2a data using their monoclonal antibody, INFEX702, which acts by disabling Pseudomonas aeruginosa, a bacteria known to be a major pathogen of NCFB. Sanofi is currently running a separate phase 2 study testing SAR445399 as a potential treatment for the inflammatory skin condition hidradenitis suppurativa.
Swallowing faecal capsules reduces peanut allergy in six adults
Altering the gut microbiomes of people with peanut allergy using faeces donated from an allergy-free individual improved their peanut tolerance in a clinical trial
Procter & Gamble acquires Thorne for $3.8bn in bet on science-backed supplement growth
The deal, expected to close in Q4 2026, brings Thorne's clinically validated, practitioner-trusted supplement portfolio into P&G's consumer health stable — signalling mainstream consumer goods giants' accelerating move into premium VMS
CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications
CVS Health® today announced a revamp of its weight management program, making it easier for eligible adults to access clinical care, navigate medication costs and get ongoing support for GLP-1 therapy.
LLMs better than docs at providing clinical context for imaging orders
The inclusion of clinical indication is standard for imaging requisitions, but the information provided is often vague and leaves out useful context that could help radiologists.
The Beauty Of Settled Science
Commenters convinced me I made a subtle mis-step in my framing of Psychology Research Is Mostly Fine. My framing emphasized that social priming studies had failed to replicate, but that many other subfields of psychology hadn’t. This naturally led commenters to point to failed replications in other subfields. Although none of these were as bad as social priming, few or none were entirely problem-free. Instead of emphasizing the difference between social priming and other subfields, I should have emphasized the difference between settled science and novel research. Here are some of my favorite psychology findings: The brain is sculpted by reinforcement learning, and a key driver of this learning is a prediction-error-based algorithm located in the nucleus accumbens and implemented through dopamine. Psychedelic drugs exert their effects through 5-HT2A receptors, pointing to a role for these receptors in some sort of construct like the balance between priors and new evidence. Certain cognitive functions are localized to certain brain areas (for example, impulse control to the frontal lobes; linguistic structure to Broca’s area, linguistic meaning to Wernicke’s area. But injure one of these areas, or render a certain function useless (eg a blind person having no more use for their visual cortex), and these mappings can gradually shift - suggesting that neurons are general-purpose compute whose specialization is a contingent fact about convenience and efficiency rather than a necessity. Most personality traits and general capabilities are about 50% genetic and 50% random, with little role for family environment or childhood history, with a few notable exceptions like partisan preference. Recent research complicates this story, but the further you go from this basic picture, the gnarlier the chains of indirect causation you require. Neurons fire together in “brain waves”, whose exact frequency corresponds with the character of consciousness; These divide neurons into natural subpopulations and linked graphs. The gamma rhythm corresponds surprisingly well to items in conscious awareness. GABA receptors seem to be involved in something like relaxation. By hitting different GABA receptors in different ways, you can modulate the exact type of relaxation you produce. Hitting GABA-A directly is too powerful and can cause dangerous levels of sedation, but allosteric modulation of GABA is an incredibly fruitful strategy that underlies drugs from benzos to barbituates to alcohol. If you know your GABA-A subunits, you can target specific subtypes of relaxation; for example, Ambien hits GABA-A1 and induces sleep. Memory divides somewhat fuzzily into bins of immediate-sensory, short-term, and long-term, with separate retrieval and storage functions, and separate systems for declarative vs. procedural learning. These can be harmed selectively, usually by hippocampal injury, so that some patients can remember their life stories but not form new long-term memories, or learn new skills like bike-riding but not new facts. The exact substrate of memory is unclear but seems to involve new synaptic connections between neurons in at least some way. The ability of modern psychology and psychiatry to treat mental illness is real but limited. SSRIs work for half or slightly fewer than half of patients; antipsychotics work with extreme side effects; benzodiazpines work but produce addiction and tolerance in many (not all) people. Most supplements are stuck in Poor Quality Study Replication Crisis Hell, but melatonin and l-theanine stand out as especially promising. Psychotherapy works with moderate effect size, but (with a few exceptions) seems to be more about the relationship with the provider than the details of the therapy itself. Mental hospitalization can sometimes defuse immediate crises but work less well than mental hospitals would like, with some studies showing overall negative effects. Schizophrenia is mostly genetic, but risk also increases with prenatal infection (especially rubella) and obstetric complications; there is suggestive evidence for roles of social stress and drug use (with psychedelics and marijuana making things worse, and nicotine if anything making things better). Bipolar and schizophrenia are so closely linked on a pathophysiological level that it seems like they might be the same disease; on the clinical level, they do seem to follow two separate courses/prognoses but can sometimes surprise clinicians by eg someone who seemed condemned to permanent schizophrenia unexpectedly recovering. The brain’s native reinforcement learning algorithms cash out in the phenomena of classical and operant conditioning; different reinforcement schedules reinforce at different levels, which can be exploited by bad actors to make especially compelling products (eg slot machines). None of these are immune to doubt. A few are speculative; one or two are genuinely unorthodox. But they’re all a step above one p = 0.049 paper that might not replicate. If they get overturned, they’ll be overturned by the same sort of genuine scientific shift that replaced Ptolemy with Copernicus or Lamarck with Darwin, not some sort of sordid discovery about someone entering random numbers into a spreadsheet. In 2008, Eliezer Yudkowsky wrote about The Beauty Of Settled Science: If you only care about scientific issues that are controversial, you will end up with a head stuffed full of garbage. The media thinks that only the cutting edge of science is worth reporting on. How often do you see headlines like “General Relativity still governing planetary orbits” or “Phlogiston theory remains false”? So, by the time anything is solid science, it is no longer a breaking headline. “Newsworthy” science is often based on the thinnest of evidence and wrong half the time—if it were not on the uttermost fringes of the scientific frontier, it would not be breaking news. Scientific controversies are problems so difficult that even people who’ve spent years mastering the field can still fool themselves. That’s what makes for the heated arguments that attract all the media attention. Worse, if you aren’t in the field and part of the game, controversies aren’t even fun. Don’t be embarrassed to read elementary science textbooks, either. If you want to pretend to be sophisticated, go find a play to sneer at. If you just want to have fun, remember that simplicity is at the core of scientific beauty [...] A steady diet of science news is bad for you: You are what you eat, and if you eat only science reporting on fluid situations, without a solid textbook now and then, your brain will turn to liquid. Psychology isn’t centrally the new paper in Annals Of Recently-Breaking News saying that an n=5 study showing that large portion sizes increase support for terrorism. Psychology is centrally ideas like brain waves, GABA receptors, reinforcement learning, twin studies, and connectionism. People who think differently are worrying too much about BREAKING NEWS!!!, and should stop. The key distinction isn’t “recent research in social psychology” vs. “recent research in cognitive/bio/behavioral psychology”, as my essay last week unfortunately implied. It’s recent research in general vs. the deposit of settled science, battle-tested hypotheses, and carefully-earmarked speculation. And part of the reason social priming in particular was such a disaster was that it defied that heuristic, building itself up over hundreds of studies until it approached or even entered the pantheon of settled science - before collapsing (5-HTTLPR was also sort of like this). This isn’t a claim that settled science is always right - Freud was “settled science” for a long time - just that there’s an intuitive distinction between the level of credence you should have in the existence of power posing vs. the existence of Broca’s Area. (I compounded this error by calling the last post “Psychology Research Is Mostly Fine”, which suggested I was talking about the new research rather than the settled science. I actually meant to distinguish between research-psychology-the-field vs. clinical-psychology-aka-therapy, but this framing unintentionally pushed against the point I wanted to make) Some commenters on the previous article understood this point, but challenged its weight. It’s very cool, they said, to know how many neurons are in which brain lobe, but the main way that Psychology affected their lives was through bad clickbait studies used to buttress dumb policies; some p = 0.049 study says that exposure to microaggressions makes minorities’ brains shrivel into raisins, and now their company has to implement punitive DEI or be sued for hazardous work conditions. I won’t dispute this as an accurate description of how the sausage gets made, but it’s worth examining the trains of thought that connect this observation to a campaign against psychology in general: The dumb woke psychology was wrong and bad, and I don’t have good heuristics for distinguishing dumb woke psychology from other psychology, so I’m going to assume it’s all wrong and bad. The dumb woke psychology was wrong and bad; it seems useful to punish/discredit psychology as a whole to assist my campaign against it, so for propaganda purposes I will try to discredit psychology as a whole. To people in the first camp, my response is: come on, your heuristics aren’t that bad. “Microaggressions makes minorities’ brains shrivel up like raisins” is in the woke category; “the hippocampal theta rhythm seems to be associated with both memory and pathfinding, suggesting an unexpected yet surprisingly compelling relationship between the two” is in the not-woke category, don’t play dumb here. To people in the second camp, my response is: deliberately exaggerated propaganda campaigns are bad and this is a confession, not an excuse. Inability to view science through anything but a political lens was what got us into this problem; doubling down on it is a temporary solution but a recipe for permanent disaster. If you pronounce entire fields of science to be acceptable collateral damage in your campaign against bad political actors, you will alienate not just scientists but patients, clinicians, and general lovers of truth. Instead, you can say the thing you mean - that woke partisans shouldn’t try to occupy and exploit the otherwise-noble science of psychology for their own political gain - and wage the same campaign with a halo rather than a comic-book-villain goatee. From the font of oracular wisdom that is Weird Sun Twitter: [ Vessel Of Spirit@VesselOfSpirit i love you all conditionally but i love the good part of you unconditionally. even if it becomes a very small part 2:11 AM · Jan 22, 2015 1 Reply · 5 Reposts · 29 Likes ](https://x.com/VesselOfSpirit/status/558084551772471298) This is how I feel about psychology1, too, but with a touch more optimism. The good part of psychology is enormous, a hoard of endless treasures. You just have to look past the headlines! 1 To play devil’s advocate - should one always be so magnamious? Astrology? Phrenology? These seem different in that their entire orientation was flawed from the start; they didn’t simply fail to find the correct constellation-personality connections, the whole project of searching for connections between constellations and personality was doomed from the start. More difficult might be asking the same question about education research, which is notoriously bad. I don’t know enough about education research to know if there’s some settled science of correct and enlightening results lurking in the background beyond the day-to-day froth of poorly-conducted and politically-motivated studies. I think if it’s 90% bad, 10% good, it’s correct to call it bad as a compact way of communicating a useful truth; I think psychology is better than that, but admit it’s a tough judgment call.
Fidji Simo had to leave OpenAI. But she’s still building a business that could find cures to chronic diseases that affect women like her
ChronicleBio is using AI to improve clinical trials and find cures for diseases like POTS.
Robert Wood Johnson University Hospital, Cooperman Barnabas Medical Center Named Best Hospitals by U.S. News & World Report
RWJBarnabas Health hospitals are once again recognized for delivering exceptional patient care and outstanding clinical outcomes in the 2026-2027 U.S. News & World Report Best Hospitals edition for adult healthcare services.
Capricor’s Duchenne AdCom Didn’t Fail on Science. It Failed on Statistics.
FDA's CTGTAC voted 9-3 against Capricor's deramiocel on July 30, 2026. The science wasn't the problem. The statistical methodology was — and the FDA let it get…
Clinical Trials Aren’t the Only Way to Know if Flu Shots Work
With a bit of creativity, evidence can be drawn from data we already have in the form of natural experiments, write Christopher M. Worsham and Anupam B. Jena.
Are AI scribes useful tools in medical education, or a crutch that imperils learning?
Educators want future physicians to be fluent in AI scribes, but they worry what off-loading clinical notes to AI could do to learning.
Panama: Haemophilus influenzae meningitis case reported in Veraguas Health Region
The Veraguas Health Region, located in the central-western region of Panama, confirmed a case of meningitis caused by the Haemophilus influenzae bacteria in a 12-year-old student from La Primavera School, diagnosed on July 29. The patient remains hospitalized, is receiving appropriate treatment, and is in stable clinical condition. The regional health director of Veraguas, Xavier A. Torres Domínguez, reported that, once the diagnosis was confirmed, the Ministry of Health (Minsa), in coordination with the Social Security Fund (CSS), immediately activated the epidemiological investigation and health response protocols established for this type of event. Canada: Haemophilus influenzae type B outbreak in Calgary As part of the actions implemented, the Epidemiology teams carried out the identification and monitoring of the patient’s close contacts, applying the corresponding preventive measures to reduce the risk of transmission and safeguard the health of the educational community. Health authorities explained that meningitis caused by Haemophilus influenzae is a bacterial disease that requires timely medical attention. In that regard, they urged the population to immediately seek medical attention if they experience symptoms such as high fever, severe headache, stiff neck, vomiting, drowsiness, or altered mental status. They also reiterated that vaccination is the main preventive measure against this disease, and therefore called on parents and guardians to verify that their children’s immunization schedules are complete, in accordance with the Expanded Program on Immunization (EPI). Outbreak News Today is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
Global Health program builds future nursing leaders through clinical immersion in Zambia
Students from the UT San Antonio School of Nursing gaining a global perspective on health and cross-cultural care.
Qureight raises $20M to expand AI-powered imaging research platform
The company specializes in providing end-to-end imaging and enterprise services for clinical trials that focus on diseases of the lung and heart.
“Cognitive Spoofing”: How AI Fakes Expertise, And Why It’s A Huge Problem In Healthcare
AI systems have to be pressure-tested in real-world clinical settings to ensure correct reasoning, accuracy and reliability.
Learning from routine health system data builds better neuroimaging AI models
Nature Medicine - We trained a three-dimensional visual foundation model directly on 5.24 million routine clinical computed tomography (CT) and magnetic resonance imaging (MRI) image series so that...
Equity and Engagement Partners with University of Illinois to Host Mental Health First Aid Training
Dr. Regina Parnell Clinical Service Manager within the Equity and Engagement Department teamed up this week with the University of Illinois Office of the Vice Chancellor for Student Affairs to host two day long Mental Health First Aid sessions.
Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trials
Hilleman Laboratories, a Singapore-based joint venture between Merck and the global charity Wellcome, is gearing up to manufacture doses of a promising experimental vaccine against the rare Bundibugyo strain of Ebola responsible for a fast-spreading outbreak in the Democratic Republic of Congo.
Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trials
CHICAGO, July 30 (Reuters) - Hilleman Laboratories, a Singapore-based joint venture between Merck and the global charity Wellcome, is gearing up to manufacture doses of a promising experimental vaccin...
RWJBarnabas Health and Rutgers Researchers Find AI Tool Helps Detect Patient Deterioration Earlier, Reducing Hospital Deaths
Researchers from RWJBarnabas Health and Rutgers Robert Wood Johnson Medical School found that an artificial intelligence (AI)-enabled early warning system helped identify hospitalized patients at risk of rapid clinical decline sooner, contributing to fewer deaths among high-risk patients.
CTSI gets more than $29 million in new funding
The Clinical & Translational Science Institute at URochester received the research dollars from the National Institutes of Health.
Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated
In this edition of AI Prognosis: A conversation about benchmarking leading clinical chatbots, investor view on AI in biopharma, and more.
Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th
Company to host public Earnings call on August 5th at 8:00 am ET / 6:00 am MT / 1:00 pm BSTSalt Lake City, UT, July 29, 2026 (GLOBE NEWSWIRE) -- Salt Lake City, UT, July 29, 2026 (GLOBE NEWSWIRE) – Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its second quarter 2026 financial results on Wednesday, August 5, 2026, before the open of the financial markets. Recursion will h
UConn Health Minute: Hypothyroid Study
A UConn Health clinical trial is exploring a promising new treatment option for people with hypothyroidism. Learn how the study aims to improve symptoms and ...
Clinical and Translational Science Institute Celebrates $29 Million Award and 20 Years of Impact
The University of Rochester Medicine Clinical and Translational Science Institute (CTSI) received grants totaling more than $29 million from the National Institutes of Health (NIH) to support translational science and research that improves human health outcomes.
Clinical chatbots are taking medicine by storm. Should doctors trust them?
As LLMs compete for doctors' attention, some developers say the science of benchmarking their AI tools for safety and accuracy is flawed.
This eating habit could help boost brain health, study finds
The study was a six month clinical trial and its findings were presented at NUTRITION 2026, the annual meeting of the American Society for Nutrition.
UT Health San Antonio uncovers potential strategy for safer cancer treatments
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, July 27, 2026 – Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), have found a potential path to maintaining the cancer-fighting benefits of one type of immunotherapy while limiting harmful […]
KGK Science secures investment to expand nutraceutical clinical research
North American nutraceutical CRO KGK Science will use growth investment from Maxim Partners to expand clinical trials, decentralised research and regulatory services for dietary supplement and consumer health companies
On Demand: Bridging Community and Clinical Approaches ─ Region 7 Maternal Health ECHO® Session 2
Session 2 of the Region 7 Maternal Health ECHO series explored ways to strengthen maternal care by connecting community support with clinical expertise.
OraCMU oral probiotic gains Health Canada approval
Stratum Nutrition is expanding its clinically researched oral probiotic ingredient OraCMU into Canada after securing a Health Canada product licence
Recap: Sporting KC suffers 4-0 defeat at LAFC
Sporting Kansas City (4-11-2, 14 pts.) suffered a 4-0 defeat against LAFC (10-5-3, 33 pts.) at BMO Stadium on Saturday. Three clinical counter attacks in the first half put Sporting into a halftime deficit before LAFC added a fourth goal late on. Head coach Raphael Wicky made one change from
Ask the Intern: Dhruv Shah at Catholic Health Mercy Hospital
The master's student in mental health counseling at NYU is building his clinical experience in the psychiatric unit
Tower Health and Jefferson Health have formed a clinical affiliation
Tower leadership, governance, and day-to-day operations will remain unchanged as the affiliation takes shape, Tower said.
Adrienne Bohl joins Essentia Health-Jamestown Clinic to practice behavioral health
The Essentia Health-Jamestown Clinic is proud to welcome Adrienne Bohl, a licensed clinical social worker in behavioral health.
Entertainment lineup announced for Delco’s Illumination 250 Festival
Plus, Delco libraries invite residents to check out new litter kits to help clean up communities; and eligible Delco residents can submit an application for free clinical medical assistant program to prepare for new career.
Girl, 6, Died After Experimental Gene-Editing Treatment in China: Science
A young girl died after receiving an experimental gene-editing treatment in a clinical trial in Shanghai, Science reported, raising questions about regulatory oversight and transparency as China rapidly expands its biotechnology ambitions.
How to Regulate AI Without Stifling Health Innovation
LDI experts discuss the current landscape and questions around regulating clinical AI systems on the state- and federal-levels.
Wright State University and Premier Health Nursing Academy expands affordable pathway to nursing careers amid growing demand
Financial support, paid clinical experience and a direct connection to Premier Health are helping Wright State nursing students graduate with less debt while building a stronger local healthcare workforce. Continue reading →
Florida-Based Science and Technology Company Crescel Announces Landmark Peer-Reviewed Medical Publication
Crescel LLC, a Florida-based innovative science and technology company, today announced publication of its landmark PubMed-indexed, peer-reviewed clinical study showing that its biobotanical technology produced statistically significant improvements over the leading prescription standard of care for rosacea in a randomized, double-blind, controlled clinical trial. Published in the Journal of Cosmetic Dermatology, the study represents a major scientific milestone for the company's pioneering prop
HHS to convene experts on standards for clinical AI
In this edition of STAT Health Tech: HHS is inviting experts to shape policy on clinical AI, Whoop's new CMO, news about brain implants, and more.
Teladoc Health unveils new virtual care model for employers, health plans that ties payment to results
Teladoc Health unveiled a new virtual care model for employers and health plans designed to offer a more coordinated, personalized approach for members, while tying payment to clinical and financia | Teladoc Health unveiled a new virtual care model for employers and health plans designed to offer a more coordinated, personalized approach for members, while tying payment to clinical and financial outcomes.
Clinical Mental Health Counseling Alumnus Q&A
In this Q&A, Brennan Champagne looks back on his time in the Clinical Mental Health Counseling program and highlights what he learned from the experience.
DIII Management Council approves amendment to guidelines on reinstating student-athletes who commit sports-betting violations
At its meeting this week, the Division III Management Council approved an amendment to the Division III Committee on Student-Athlete Reinstatement sports-betting guidelines. The council’s action would allow for penalty reductions for a student-athlete who commits a sports-betting violation, provided it is the student-athlete’s first violation, the violation does not involve integrity concerns and the student-athlete engages in appropriate clinical evaluation or support.
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS
/PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing disease-modifying...
Biotech experts want FDA drug reviews based on science, not politics
Biotech experts and industry executives are calling plans by the U.S. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Biotech experts want FDA drug reviews based on science, not politics
Biotech experts and industry executives are calling plans by the U.S. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Biotech experts want FDA drug reviews based on science, not politics
July 22 (Reuters) - Biotech experts and industry executives are calling plans by the U. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Devonian’s Phase II/III Thykamine paediatric study secures Health Canada approval
Devonian Health Group has received authorisation from Health Canada for its CTA to begin a Phase II/III study of Thykamine cream to treat mild-to-moderate atopic dermatitis in paediatric patients.
3 newsy must-reads on AI in healthcare (plus 3 bonus picks)
1.) Some clinical AI has a fuzzy ROI. That doesn’t mean it shouldn’t be reimbursed. 2.) What makes biomedical research different from other sectors where AI has been quickly adopted? 3.) Unmoved by enthusiasm, health execs are making AI decisions around organizational priorities.
SGMC Health Releases FY2025 Annual Report Highlighting Regional Impact and Strategic Growth
SGMC Health has released its Fiscal Year 2025 Annual Report, highlighting continued growth across key clinical services, workforce development, and a campus expansion that strengthens healthcare access across South Georgia and North Florida.
Lilly’s $2.8 Billion Bet on Psychedelics Buys Science That Conventional Trial Infrastructure May Not Be Able to Run
Eli Lilly acquires AtaiBeckley for $2.8B, but the FDA's final psychedelic trial guidance reveals an operational crisis Big Pharma hasn't priced in.
Radiology Partners names new head of clinical services
The country’s largest imaging group, with over 4,000 radiologists on its payroll, is tapping a former Universal Health Services exec to serve as president of its patient care division.
Emergency nurses know what it’s like to suffer pangs of moral distress
Like the emergency physicians they work alongside, ER nurses experience moral distress in substantial numbers and multifaceted ways, according to a new study published in the Journal of Clinical Nursing.
DOH-Charlotte Expands Clinical Services to Include School and Sport Physicals and EKGs - Florida Department of Health in Charlotte County
The Florida Department of Health in Charlotte County is expanding its clinical services to include school and sport physicals and electrocardiograms (EKGs).
HHS vaccine committee quietly gets new charter
Lax clinical oversight for online GLP-1 prescriptions, proposed financial help for people who want to quit smoking, and more health news
Bayer and Henry Ford Health partner to boost clinical trial access
Bayer and Henry Ford Health have entered a strategic research partnership aimed at expanding access to clinical trials for patients.
Samyang Roundsquare Launches Spindle, a Science-Led Metabolic Health Brand Focused on the Gut–Muscle Connection
Samyang Roundsquare announces the launch of Spindle, a science-led metabolic health brand with its debut product, Spindle Muscle+, to redefine how adults think about strength and aging. Spindle Muscle+ is powered by Akkermansia MYO™, a clinically studied strain shown to support muscle strength, through the gut.
The Blood-Brain Barrier Has Been Breached. Is Clinical Trial Science Ready?
FDA's March 2026 approval of AVLAYAH marks the first BBB-crossing biologic — but CNS trial design, PK monitoring, and safety frameworks haven't caught up.
Common antidepressant may ease long COVID’s crushing fatigue
A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue. In a randomized clinical trial involving 399 adults, fluvoxamine significantly reduced fatigue and improved quality of life compared with a placebo, making it one of the first medications to show meaningful benefits for this disabling condition.
School of Medicine and Tanner Health celebrate opening of Carrollton Clinical Campus and Simulation Lab
CARROLLTON, Ga. – The Carrollton community and leaders from across the state of Georgia gathered at Tanner Medical Center/Carrollton on Friday, July 17, to celebrate the opening of Mercer University…
The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long”
The United States has a translation problem. Scientific breakthroughs in oncology are accelerating, but clinical trial infrastructure hasn’t kept pace. The solution: Speed up clinical trial enrollment by using AI to reduce costs and eliminate bureaucratic red tape. Tasks that ordinarily require hours of manual work for each patient in a single study can now […]
GSK’s drops chronic cough drug, dampening $2bn Bellus Health bid
GSK will discontinue camlipixant’s late-stage RCC programme, though it will continue the drug’s development in two forms of IBS.
MAHA is rewriting the vocabulary of American mental health care
“‘Deprescribing’ elevated into a movement, and a cultural default, is a clinical hazard,” writes Sunny Patel.
MDCalc is scoring the clinical calculators used by millions of doctors
MDCalc is launching a quality-rating system for the more than 800 clinical calculators used to assess disease risk, transplant eligibility, and more.
New Alzheimer's drug repairs DNA damage and reduces brain inflammation
A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse studies, KCL-286 repaired dangerous DNA damage, reduced inflammation, and targeted multiple disease-related pathways instead of focusing on just amyloid or tau. Since it has already cleared an initial human safety trial, researchers believe it could move more quickly into Alzheimer’s clinical testing.
Partnering with Bunkerhill Health: AI Agents that Improve Patient Outcomes
Nish Khandwala and David Eng are building the AI agent platform to serve every function across the health system: clinical, operational, and administrative.
Medicare wants to shake up how it pays for clinical AI
In this edition of STAT Health Tech: Centers for Medicare and Medicaid Services proposes major changes to RPM, clinical AI payment models.
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and AtaiBeckley Inc. (Nasdaq: ATAI), a clinical-stage biopharmaceutical company developing innovative...
CMS signals intent to revamp how it pays for clinical software and AI
CMS wants to build a standardized payment structure for clinical software and AI that factors in their impact on patient outcomes.
The opioid offensive: Fighting fentanyl | Investors Lab
As the clinical-stage biotech sector tackles this multibillion dollar public health imperative, a mix of established players and venture-backed innovators are making strides:
Docs with greater clinical knowledge less likely to order low-value imaging
Wasteful tests and treatments, such as imaging for an uncomplicated headache, continue to plague the U.S. healthcare system, experts note.
HHS & VA Announce Bold, Comprehensive Partnership to Advance Rapid-Acting Mental Health Treatments for Veterans
HHS and the U.S. Department of Veterans Affairs entered into a Memorandum of Understanding to strengthen collaboration on the research, clinical development, and responsible deployment to veterans suffering from serious mental health conditions.
Inside this health care lab the patients aren't real, but the lessons are
Discover how The University of Alabama's Simulation Center prepares nursing students through hands-on experiential learning, building confidence, clinical skills and compassionate patient care.
Bioenergy Life Science adopts decentralised clinical research to support nutraceutical claims
The ingredient supplier says real-world decentralised studies can help brands generate finished-product evidence at lower cost while addressing growing regulatory expectations around substantiated health claims
AB Science cuts three trials in pipeline reset
French biotech AB Science is discontinuing three masitinib trials as it concentrates its clinical resources on an ALS phase 3 programme and the early-stage development of AB8939 in acute myeloid leukaemia.
2nd PET scan changes treatment for nearly half of prostate cancer patients
Managing recurrent prostate cancer after first-line treatment remains a key clinical challenge, experts write in The Journal of Nuclear Medicine.
Roche ends two Huntington’s disease drug programmes after disappointing results
⏱️ 10 min read | Roche announced it is stopping development of two of its huntingtin-lowering ASO drugs, tominersen and RG6496. This marks a disappointing end to an important chapter in HD clinical research.
HEALTH FIRST: Managing cardiac sarcoidosis and heart disease
Megan Clark, a clinical pharmacist practitioner with Novant Health’s Heart and Vascular Institute, was in the studio to discuss the disease and treatment options.
Small Business Spotlight: Business blooms beyond bouquets
BUSINESS: The Busy Bloom OWNERS: Amanda and Walter Adkins ADDRESS: 708 S. 17th St., Wilmington EMAIL: thebusybloomco@gmail.com WEBSITE: thebusybloomco.com PHONE NUMBER: (910) 742-0790 YEAR FOUNDED: 2024 NO. OF EMPLOYEES: 4 WHAT IS THE BUSY BLOOM? AMANDA ADKINS: “The Busy Bloom is a flower shop with a spin – a creative experience shop located in Wilmington’s Cargo District. Founded in 2024 by husband-and-wife team Amanda and Walter Adkins, we offer fresh flowers, botanical teas, a build-your-own bouquet bar, candle-making experiences, gifts, workshops, wedding florals and event services. Our mission is simple: to make flowers accessible, approachable and enjoyable for everyone – not just for special occasions.” WHY DID YOU START THE BUSINESS? AMANDA ADKINS: “The Busy Bloom was born from a lifelong connection to flowers and a desire to create meaningful experiences for people. After doing my own wedding florals and after years of working in healthcare management, I found myself returning to gardening and floral design as a creative outlet and source of healing. The loss of my mother-in-law, who always shared flowers from her garden, inspired me to pursue floristry full-time. My husband encouraged me and built a small flower cart for us to grow, and fast forward to now, two years later, it has grown into a community-centered business focused on bringing joy, connection and creativity through flowers.” WHAT KIND OF GROWTH ARE YOU HOPING FOR? AMANDA ADKINS: “We’re focused on sustainable growth that allows us to continue serving our community while expanding creative experiences. We hope to grow our wedding and event services, expand our educational workshops and creative programming and become a destination where people can gather, create and connect. We’re also passionate about creating opportunities that showcase floral design as an art form, such as our Fleur Couture fashion show and other community collaborations.” WHAT PAST EXPERIENCE HAVE YOU HAD WITH STARTING/WORKING IN BUSINESS? AMANDA ADKINS: “Before opening The Busy Bloom, I worked as a clinical manager in healthcare and spent years building leadership, operations and customer service skills. I’ve also worked in education and nonprofit programming, teaching people about nature and local ecosystems. Along the way, I designed flowers for weddings and events on the side, gradually turning a passion into a business. Walter has years of welding and construction experience, combined with entrepreneurship and a drive to own his own company. …The Busy Bloom has been a journey of combining creativity with entrepreneurship alongside my husband ... learning every step of the way.”
VisualDx Partners with Sun River Health to Expand Access to Clinical Decision Support for Underserved Patients
ROCHESTER, N.Y., July 08, 2026--VisualDx, a leading clinical decision support system used by healthcare professionals worldwide, today announced a new partnership with Sun River Health, a federally qualified health center (FQHC) serving patients across 50 locations in New York State. Through this partnership, Sun River Health's nearly 500 providers will use VisualDx to strengthen in-house decision-making capabilities, enable more appropriate dermatology referrals, and improve health equity for t
Spectrum Science Appoints Industry Veteran Marie Emms as President of Clinical Business
/PRNewswire/ -- Spectrum Science, an independent, full-service, strategic platform offering integrated clinical, commercial, and communications services, today...
Spectrum Science Appoints Industry Veteran Marie Emms as President of Clinical Business
/PRNewswire/ -- Spectrum Science, an independent, full-service, strategic platform offering integrated clinical, commercial, and communications services, today...
Dumbo Health Launches SleepLongevityAge, Bringing Clinical Care to the World’s Most Overlooked Health Metric
Introducing Sleep Longevity: a new category of care that turns the world’s most overlooked health metric into action. Sleep better. Live longer.Miami, Florida, July 08, 2026 (GLOBE NEWSWIRE) -- Millions of people wake up tired every morning, and most never find out why. Americans have never known more about how they sleep: Apple Watch, Oura, Whoop, Garmin, and other wearables generate millions of sleep scores every morning. Yet for most people, those scores never lead to action. Today, Dumbo Hea
Urologists continue to expand into interventional radiology with 2 new openings
Alabama-based Clinical Urology Associates is one of the latest to begin offering IR services to its patients, in partnership with Radiology of Huntsville.
New weight loss pill beats oral Ozempic in major trial
A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the leading oral semaglutide in a major clinical trial. The tablet could offer a more convenient alternative to injectable drugs like Ozempic and Wegovy because it doesn't require refrigeration or special timing with meals. It's also cheaper to manufacture, which could expand access globally.
Founder/CEO and Clinical President of Digital Health Company Sentenced
The founder and former Chief Executive Officer (CEO) Ruthia He of Done Global Inc., a California-based digital mental health company, was sentenced today to six years in prison and a $1 million fine for orchestrating a scheme that used her company’s technology platform, compensation structure, and clinical protocols to unlawfully distribute over 37 million pills of Adderall,
There's no treatment designed for the Ebola strain ravaging DRC. But now there's hope
The strain of the virus that's responsible for the current outbreak has no specific treatments or preventive measures. Three new clinical trials could provide possible breakthroughs.
Clinical care, community service shape health science major’s goals
Inspired by his parents, Platinum Liang ultimately plans to pursue medical school.
Clinical care, community service shape health science major’s goals
Inspired by his parents, Platinum Liang ultimately plans to pursue medical school.
RADPAC launches new subcommittee dedicated to teleradiology advocacy
Kimberly Beavers, MD, a clinical assistant professor and remote breast radiologist with NYU Langone Health, will serve as inaugural chair of the initiative.
IFT: Proposed US federal grant rules threaten nutrition science funding & competitiveness
The US Office of Management and Budget (OMB) recently proposed rules to rewrite the Uniform Guidance — the rulebook for all federal grants. Institute of Food Technologists (IFT) chief science and technology officer tells Nutrition Insight that these rules are set to undermine the nation’s scientific research for food and nutrition and hinder global competitiveness.
Protein lactylation in health and diseases: molecular mechanisms, biological significance, and clinical implications
Signal Transduction and Targeted Therapy - Protein lactylation in health and diseases: molecular mechanisms, biological significance, and clinical implications
Anthropic Wants to Make Its Own Drugs With Help from Claude
The AI company is launching preclinical drug programs for overlooked diseases.
Why you should wash new clothes before wearing; signs that you are aging well; effective leadership in health care; plus other stories with Vanderbilt Health sources
Jami Miller, MD, Professor of Clinical Dermatology, and David Gaston, MD, PhD, Assistant Professor of Pathology, Microbiology and Immunology, are quoted in a Southern Living piece about the importance of washing new clothes before wearing them. Dyes, chemicals, mold and bacteria are all potential troublemakers lurking around your new duds. Parul Goyal, MBBS, Associate Professor of Clinical Medicine, was quoted in a Huff Post story outlining signs that you are aging well. Tae Kon Kim, MD, PhD, Assistant Professor of Medicine, was interviewed by Healio for a story headlined, “Effective leadership in health care ‘starts with listening.’” AAMC News reporter Patrick Boyle interviewed Wes Ely, MD, Professor of Medicine and Critical Care, for a story about ICU delirium. PharmaVoice reporter Kelly Bilodeau interviewed Romney Humphries, PhD, Vice Chair and Executive Medical Director, Clinical Services, for a story about the CDC’s new data that shows an alarming increase in the prevalence of a gene that can make “nightmare bacteria” significantly harder to treat. American Community Media interviewed William Schaffner, MD, Professor of Preventive Medicine, for a piece about Ebola that was reused by several media outlets around the U.S., including The Mississippi Link. Stacie Dusetzina, PhD, Professor of Health Policy, was quoted by The Independent in a story about how Medicare will soon cover weight-loss drugs. Courtney Schadt, MD, Associate Professor of Dermatology, was interviewed by Tennessean reporter Beth Warren, about tanning safety and tanning fads circulating social media. WKRN News 2 interviewed Amanda Peltier, MD, Professor of Neurology, about the correlation between head trauma and ALS following the diagnosis of former Titans running back Chris Johnson.
How remote patient monitoring advances affordable healthcare
As global medical costs face double-digit spikes, remote care is a clinical tool and an economic necessity.